Princess Máxima Center

Running trials

• Recruiting

  Study on chemotherapy and experimental drugs in patients with Philadelphia Chromosome positive and ABL-class Philadelphia Chromosome-Like B-cell Acute Lymphoblastic Leukemia

  2025-520982-39-00· Phase 3· Universita Degli Studi Di Milano Bicocca· Source

• Recruiting

  Safety and Efficacy Study of Zamtocabtagene Autoleucel (MB-CART2019.1) in Pediatric Patients With R/R B-Cell Neoplasms

  NCT06508931· Phase 2· Miltenyi Biomedicine GmbH· Source

• Recruiting

  Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

  NCT06333899· Early phase 1· Nationwide Children's Hospital· Source

• Recruiting

  Study of Olutasidenib and Temozolomide in HGG

  NCT06161974· Phase 2· Rigel Pharmaceuticals· Source

• Recruiting

  A Multi-Arm, Platform Trial For Relapsed Neuroblastoma

  NCT07334301· Phase 1/2· University of Birmingham· Source

• Recruiting

  Targeted Pediatric High-Grade Glioma Therapy

  NCT05839379· Nationwide Children's Hospital· Source

• Recruiting

  A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer

  NCT05999994· Phase 2· Eli Lilly and Company· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers6 recruiting
• Glioblastoma3 recruiting
• Acute lymphoblastic leukaemia1 recruiting
• Neuroblastoma1 recruiting

Closed trials

• Completed

  A Phase 1 Study of of Anti-CD7 Allogeneic CAR-T Cell Therapy (WU-CART-007) in Patients With Relapsed or Refractory T-ALL/LBL

  NCT04984356· Phase 1· Allotera Therapeutics· Source

• Terminated

  A Study Evaluating the Safety, Tolerability, Pharmacokinetics and Preliminary Activity of Idasanutlin in Combination With Either Chemotherapy or Venetoclax in Treatment of Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias or Solid Tumors

  NCT04029688· Phase 1/2· Hoffmann-La Roche· Source

• Completed

  Phase 1/2 Dose Finding and Safety Study of Ibrutinib in Pediatric Subjects With Chronic Graft Versus Host Disease (cGVHD)

  NCT03790332· Phase 1/2· Pharmacyclics LLC.· Source

• Terminated

  Evaluation of 2 Intensification Treatment Strategies for Neuroblastoma Patients With a Poor Response to Induction

  NCT03165292· Phase 2· Gustave Roussy, Cancer Campus, Grand Paris· Source

• Completed

  Study Evaluating Brexucabtagene Autoleucel (KTE-X19) in Pediatric and Adolescent Participants With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia or Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

  NCT02625480· Phase 1/2· Kite, A Gilead Company· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Childhood cancers79 works · 10 trials
• Sarcoma60 works · 0 trials
• Neuroblastoma47 works · 3 trials
• Acute lymphoblastic leukaemia33 works · 4 trials
• Acute myeloid leukaemia27 works · 1 trial
• Hodgkin lymphoma11 works · 0 trials